1
Registered trials
1
Recruiting
1
Unique sponsors
13
Unique IMPs
0
Commercial trials
Drug classes (ATC)
B
Haematology (ATC B)
1
L
Oncology (ATC L)
1
V
Various (ATC V)
1
Mechanism of action (INN-stem analysis)
Alkylating agent
3 substances
Supportive / diluent
3 substances
Platinum compound
2 substances
Monoclonal antibody (chimeric)
1 substance
Anthracycline
1 substance
Topoisomerase II inhibitor
1 substance
Unknown / small molecule
1 substance
Vinca alkaloid
1 substance
Phase I/II:
1
Phase I/II
1 trial-
RecruitingPrinses Maxima Centrum voor Kinderoncologie B.V. AcademicCARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DINUTUXIMAB BETA; DOXORUBICIN HYDROCHLORIDE; ETOPOSIDE; GLUCOSE; HUMAN ALBUMIN SOLUTION; IFOSFAMIDE; SODIUM CHLORIDE; VINCRISTINE SULFATE; WATER FOR INJECTION
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Prinses Maxima Centrum voor Kinderoncologie B.V. | Academic | 1 | Phase I/II | 1 |
New trials by year
2024
1